Infant Mortality
15
1
2
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
6.7%
1 terminated out of 15 trials
90.0%
+3.5% vs benchmark
53%
8 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (15)
Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality?
Biological Impacts of Rising Temperatures on Maternal, Fetal, and Newborn Health: A Cohort Study (BIRTH Cohort)
BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa
Enrichment of Human Milk With Human and Bovine Milk-based Fortifiers for Very Preterm Infants: a Meta-analysis
Antenatal Micronutrient Supplementation and Infant Survival
Today Not Tomorrow Pregnancy and Infant Support Program (TNT- PISP)
Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial
Comparing Morbidity and Mortality Effects of Two Different Strains of BCG
Integrating Pediatric Care Delivery in Rural Healthcare Systems
Reduction of Adverse Pregnancy Outcomes With a Smartphone Application in Ghana
Antenatal Micronutrient Supplementation and Birth Weight
Assessing the Impact of Smoke-free Legislation on Perinatal Health in the Netherlands
Impact of Smoke-free Legislation on Early-life Mortality and Low Birth Weight in England
Vitamin A Supplementation With Bacille Calmette Guerin (BCG) Vaccine
Impact of Maternal Vitamin A or Beta-Carotene Supplementation on Maternal and Infant Mortality in Bangladesh